Showing 61 to 72 of 151 results
Trump Administration Launches Section 232 Investigations into Pharmaceutical and Semiconductor Imports
The Trump administration launched investigations into pharmaceutical and semiconductor imports under Section 232, potentially imposing tariffs within 270 days; public comments are due in 21 days, and the move follows similar actions on steel, aluminum, and automobiles.
Trump Administration Launches Section 232 Investigations into Pharmaceutical and Semiconductor Imports
The Trump administration launched investigations into pharmaceutical and semiconductor imports under Section 232, potentially imposing tariffs within 270 days; public comments are due in 21 days, and the move follows similar actions on steel, aluminum, and automobiles.
Progress
44% Bias Score
Trump Reconsiders Auto Tariffs, Threatens Pharmaceutical Tariffs
President Trump is considering temporary exemptions from auto tariffs to allow automakers time to reshore production, while simultaneously threatening similar tariffs on pharmaceutical products to encourage domestic manufacturing; details on timing and scope remain unclear.
Trump Reconsiders Auto Tariffs, Threatens Pharmaceutical Tariffs
President Trump is considering temporary exemptions from auto tariffs to allow automakers time to reshore production, while simultaneously threatening similar tariffs on pharmaceutical products to encourage domestic manufacturing; details on timing and scope remain unclear.
Progress
44% Bias Score
Trump Administration Launches Investigations into Pharmaceutical and Semiconductor Imports, Threatening Tariffs
The Trump administration is investigating pharmaceutical and semiconductor imports to impose tariffs on national security grounds, setting a 21-day public comment period before a potential 270-day investigation completion; this follows previous actions leading to tariffs on steel, aluminum, and auto...
Trump Administration Launches Investigations into Pharmaceutical and Semiconductor Imports, Threatening Tariffs
The Trump administration is investigating pharmaceutical and semiconductor imports to impose tariffs on national security grounds, setting a 21-day public comment period before a potential 270-day investigation completion; this follows previous actions leading to tariffs on steel, aluminum, and auto...
Progress
40% Bias Score
Future Pak Bids US$255 Million for Theratechnologies
Future Pak, an American pharmaceutical packaging company, made a US$255-million cash offer to acquire Canadian drug developer Theratechnologies, prompting the company to form a special committee to review the proposal and consider other potential suitors.
Future Pak Bids US$255 Million for Theratechnologies
Future Pak, an American pharmaceutical packaging company, made a US$255-million cash offer to acquire Canadian drug developer Theratechnologies, prompting the company to form a special committee to review the proposal and consider other potential suitors.
Progress
44% Bias Score
Trump's Pharmaceutical Tariffs Threaten Global Markets
President Trump announced imminent pharmaceutical tariffs, potentially impacting India (6% of US imports) and European countries like Ireland, Germany, and Switzerland which export significant amounts to the US, sparking concerns over global supply chains and higher drug costs.
Trump's Pharmaceutical Tariffs Threaten Global Markets
President Trump announced imminent pharmaceutical tariffs, potentially impacting India (6% of US imports) and European countries like Ireland, Germany, and Switzerland which export significant amounts to the US, sparking concerns over global supply chains and higher drug costs.
Progress
44% Bias Score
EU Pharma Industry Warns Against US Tariffs, Risks to Supply Chains Highlighted
Representatives from major European pharmaceutical companies and trade organizations warned the EU against imposing tariffs on US goods, citing potential supply chain disruptions and harm to patients, during a video call on Tuesday. The sector narrowly avoided tariffs in the latest round but remains...
EU Pharma Industry Warns Against US Tariffs, Risks to Supply Chains Highlighted
Representatives from major European pharmaceutical companies and trade organizations warned the EU against imposing tariffs on US goods, citing potential supply chain disruptions and harm to patients, during a video call on Tuesday. The sector narrowly avoided tariffs in the latest round but remains...
Progress
40% Bias Score
Trump Administration Investigates Imports of Chips and Pharmaceuticals, Citing National Security
The Trump administration launched investigations into imports of computer chips, chip-making equipment, and pharmaceuticals, citing national security concerns and aiming to boost domestic production, potentially imposing new tariffs.
Trump Administration Investigates Imports of Chips and Pharmaceuticals, Citing National Security
The Trump administration launched investigations into imports of computer chips, chip-making equipment, and pharmaceuticals, citing national security concerns and aiming to boost domestic production, potentially imposing new tariffs.
Progress
48% Bias Score
Trump Administration Launches Investigations into Pharmaceutical and Semiconductor Imports
The Trump administration launched investigations into pharmaceutical and semiconductor imports on Monday, potentially leading to tariffs under the 1962 Trade Expansion Act; public comment is due in 21 days, with investigations to conclude within 270 days.
Trump Administration Launches Investigations into Pharmaceutical and Semiconductor Imports
The Trump administration launched investigations into pharmaceutical and semiconductor imports on Monday, potentially leading to tariffs under the 1962 Trade Expansion Act; public comment is due in 21 days, with investigations to conclude within 270 days.
Progress
36% Bias Score
Trump Hints at New Tariffs on Chinese Electronics, Pharmaceuticals
President Trump is considering imposing new tariffs on Chinese-made smartphones and other electronics as early as Monday, potentially impacting U.S. consumers and major tech companies like Apple, Dell, and Nvidia after previously granting temporary exemptions. This follows a similar threat towards C...
Trump Hints at New Tariffs on Chinese Electronics, Pharmaceuticals
President Trump is considering imposing new tariffs on Chinese-made smartphones and other electronics as early as Monday, potentially impacting U.S. consumers and major tech companies like Apple, Dell, and Nvidia after previously granting temporary exemptions. This follows a similar threat towards C...
Progress
60% Bias Score
Bayer's 7% Revenue Growth in Spain Driven by Innovation and Investment
In 2024, Bayer's Spanish operations reported €822 million in revenue (a 7% increase), driven by pharmaceuticals, agriculture, and consumer health products; €145 million was invested, with €118 million dedicated to R&D and €27 million to efficiency improvements; Viralgen, a Bayer subsidiary specializ...
Bayer's 7% Revenue Growth in Spain Driven by Innovation and Investment
In 2024, Bayer's Spanish operations reported €822 million in revenue (a 7% increase), driven by pharmaceuticals, agriculture, and consumer health products; €145 million was invested, with €118 million dedicated to R&D and €27 million to efficiency improvements; Viralgen, a Bayer subsidiary specializ...
Progress
40% Bias Score
Trump's Threat to Irish Pharma: 21,500 Jobs at Risk
Donald Trump's threat to US pharmaceutical companies operating in Ringaskiddy, Ireland, jeopardizes 21,500 direct jobs and thousands more indirectly, impacting Ireland's €44.4bn pharmaceutical export sector and potentially causing significant economic and social disruption.
Trump's Threat to Irish Pharma: 21,500 Jobs at Risk
Donald Trump's threat to US pharmaceutical companies operating in Ringaskiddy, Ireland, jeopardizes 21,500 direct jobs and thousands more indirectly, impacting Ireland's €44.4bn pharmaceutical export sector and potentially causing significant economic and social disruption.
Progress
44% Bias Score
EU Pharmaceutical Stocks Plummet on US Tariff Threat
The threat of new US tariffs on pharmaceutical imports caused a significant drop in European and Indian pharmaceutical stocks, prompting warnings of a 'flight risk' to the US and leading EU pharmaceutical companies to request immediate policy changes from the EU President to prevent billions of euro...
EU Pharmaceutical Stocks Plummet on US Tariff Threat
The threat of new US tariffs on pharmaceutical imports caused a significant drop in European and Indian pharmaceutical stocks, prompting warnings of a 'flight risk' to the US and leading EU pharmaceutical companies to request immediate policy changes from the EU President to prevent billions of euro...
Progress
40% Bias Score
Showing 61 to 72 of 151 results